Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy

Cancer is the second leading cause of death worldwide after cardiovascular diseases. Harnessing the power of immune cells is a promising strategy to improve the antitumor effect of cancer immunotherapy. Recent progress in recombinant DNA technology and antibody engineering has ushered in a new era o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Ha Gyeong, Yang, Ha Rim, Yoon, Aerin, Lee, Sukmook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146966/
https://www.ncbi.nlm.nih.gov/pubmed/35628495
http://dx.doi.org/10.3390/ijms23105686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146966/
https://www.ncbi.nlm.nih.gov/pubmed/35628495
http://dx.doi.org/10.3390/ijms23105686

Ejemplares similares